Senegal summary indicators
| Baseline costing indicators | 2001 |
| GDP per capita1 | $413 |
| Population2 | $10,597,841 |
| Surviving infants2 | 369,762 |
| DTP-3 coverage3 | 89% |
| Total health expenditure per capita (current $)4 | $20.4 |
| Total spending on routine immunization5 | $2,407,269 |
| - per DTP-3 immunized child | $7.3 |
| - per capita | $0.23 |
| - as a % of overall health expenditure | 1.1% |
| Total spending on the NIP (including campaigns)5 | $3,333,024 |
| - as a % of overall health expenditure | 1.5% |
| Future resource requirements, financing and gaps5 | 2003-2008 |
| Avg. annual resource requirements | $6,252,357 |
| - % new-underused vaccines | 62.5% |
| - per DTP-3 targeted child | $17.9 |
| Avg. annual secure funding | $5,305,552 |
| - % from government | 46.0% |
| - % from GAVI-Vaccine Fund | 46.1% |
| - % from other donors | 7.8% |
| Avg. annual probable funding | $0 |
| Avg. annual funding gap (secure and probable funding) | $946,805 |
| - % of resource requirements | 15.1% |
| - per DTP-3 targeted child | $2.7 |
Sources:
- World Development Indicators - World Bank for GDP
- United Nations Population Division, Department of Economic and Social Affairs, World Population Prospects the 2002 Revisions
- WHO-UNICEF Coverage Best Estimates
- WHO - World Health Report 2003, 2004 and 2005
- Immunization Financing Database. Immunization specific spending is reported.